-
Forward Look
Bridging the DistanceQ&A with medical oncologist Ana María López, medical director of the telemedicine program at the University of Arizona Cancer Center in Tucson.
by Sue Rochman
-
Forward Look
Treading Carefully With Medical ScansTo reduce your long-term cancer risk, make sure the tests are justified.
by Ingfei Chen
-
Forward Look
A Trojan Horse to Fight CancerAn experimental treatment shows the potential of a new family of targeted drugs.
by Stephen Ornes
-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
A Genetic Legacy
Doctors now know more than ever about the inherited cancer-related mutations that can link generations of family members. But with the new knowledge from scientific advances and DNA testing come new questions for patients.
by Sue Rochman
-
Forward Look
Healthy Lifestyle, Healthier ChromosomesQ&A with Elizabeth Blackburn, professor of biochemistry and physiology at the University of California, San Francisco.
by Rabiya Tuma
-
Forward Look
An Aspirin a Day …A link between the popular remedy and cancer prevention needs to be borne out in clinical trials.
by Stephen Ornes
-
Forward Look
A Diabetes Drug for Cancer?Lab results spur researchers to test low-cost medication on humans.
by Stephen Ornes
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon